vialroom

#tirzepatide 2026-03-24

Tuesday31 messages8 participantstimes are UTC
Highlights from this day
  • mg_per_ml — slightly off topic but the trials titrated every four weeks to a target, most people here stop at whatever works 16:30
  • group_buy_gwen — does the appetite effect feel different or just stronger 16:31
  • group_buy_gwen — my Janoshik result on a FGP vial came in at 98.6 which is why i keep buying from them 18:08
  • apnoea_down_two — SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted 18:11
MO

changed my mind about needing 15, i was chasing a number rather than an outcome

whats the top licensed dose, 15 or does it go higher

VB

Reminder for mg_per_ml: dose day is today. Set 2 days ago.

MO

no gap when i switched, took the last semaglutide dose and started this a week later

licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does

MO

i log everything and my appetite curve looks flatter across the week than my semaglutide log did

MP

back after 6 months, do i restart at 2.5 or pick up near where i left off

MP

slightly off topic but the trials titrated every four weeks to a target, most people here stop at whatever works

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
NN

there is no clean conversion between the two, anyone giving you a ratio is guessing

CO

the sweet spot thing is survivorship, the people it worked for stayed and said so, thats just me

AD

the 2.5 to 5 step was the roughest one for me and everything after was easier, take that with a pinch of salt

NN

went back to semaglutide after 24 months because the cost difference mattered more than the GI

📈2🧪7
AD

if youre coming off semaglutide the honest answer is start low and find out, theres no table

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
GB

folklore probably

Cited study
Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4)
JAMA · 2024
Randomised withdrawal after a 36-week lead-in. Pairs with STEP 4.
AD

while im here the switch felt like a step down at first and then caught up around week 32

GB

my Janoshik result on a FGP vial came in at 98.6 which is why i keep buying from them

🤝10📈11🎉1

plateaued at 18 weeks the same way i did on semaglutide, so i doubt its compound specific

AD

SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted

💀10📈17🙏16

at 15 the GI came back for me, so my easier profile claim only applies below that

BB

the 2 vial in 2.5ml gives 10mg/ml which puts 2.4 on 12 units, nice round numbers

BB

the two compounds arent interchangeable week for week even if the effect ends up similar

⚠️57

10 was enough

📈4📉6
BB

for the archive the GIP explanation for easier nausea is plausible and i still treat it as a story not a fact